跳至主要内容
临床试验/IRCT20100111003043N15
IRCT20100111003043N15尚未招募3 期

Evaluation of the effect of zinc dose received through supplements for kidney diseases patients in Iran (Nephrovit® or Nephrotonic®) on iron stores and anemia in non-dialysis chronic kidney diseases patients

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Patients aged 18-85 years,
  • with stage 3 or more CKD according to the KDIGO guideline,
  • who have been treated with nephrovitis or nephrotonics for more than three months,
  • No significant changes in their diet.

排除标准

  • History of chronic infection (AIDS, bacterial, fungal or parasitic infections),
  • severe infection (sepsis) in the last month,
  • alcohol abuse,
  • use of anemia-inducing drugs (some antibiotics such as linezolid, cotrimoxazole, chloramphenicol and Isoniazid, routine use of nonsteroidal anti-inflammatory drugs, chemotherapy drugs, hydroxyurea, azathioprine, 6-mercaptoporin, sulfasalazine, and methotrexate),
  • treatment with steroids or immunosuppressant,
  • hospitalization,
  • history of blood transfusion within 1 month prior to enrollment.

研究者

相似试验

The effect of zinc dose on anemia in non-dialysis... | 临床试验